Effects of Korean Red Ginseng on Cognitive and Motor Function: A Double-blind, Randomized, Placebo-controlled Trial by 정기영 et al.
ⓒ The Korean Society of Ginseng 190 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947
Research Article
J Ginseng Res Vol. 36, No. 2, 190-197 (2012)
http://dx.doi.org/10.5142/jgr.2012.36.2.190
E-mail: leen54@chollian.net
Tel: +82-2-920-5355, Fax: +82-2-927-2836
*Corresponding author
INTRODUCTION
Ginseng roots have been used for over 2,000 years in 
many Asian countries. Panax ginseng, the herbal root of 
P. ginseng Meyer, is also known as Korean ginseng. The 
various forms of ginseng are processed differently for 
different uses. White ginseng is air-dried, whereas red 
ginseng is produced by steaming and drying. It has been 
reported that red ginseng is pharmacologically more ac-
tive than white ginseng [1]. The difference in the biologi-
cal activity of red and white ginseng may result from the 
different chemical constituents produced during process-
ing [1].
Ginseng has a complex activity profile that includes 
antioxidant, anti-inflammatory, anti-apoptotic, and im-
mune-stimulatory properties [2]. Thus, ginseng has the 
effects of stabilizing and balancing the entire physiology. 
The active components in ginseng include ginsen-
osides, polysaccharides, peptides, polyacetylenic alco-
hols, vitamins, minor elements and enzymes [2]. Ginsen-
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osides are found only in Panax species and are believed 
to be responsible for most of the activities of ginseng. 
Ginsenosides can be classified into three major groups 
based on the chemical structures of their saponins: the 
panaxadiol (Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rh2, and Rs1), 
panaxatriol (Re, Rf, Rg1, Rg2, and Rh1), and oleanolic 
acid groups (Ro). Among these, Rb1 and Rg1 play major 
roles in both stimulatory and inhibitory effects on the 
central nervous system, modulating neurotransmission. 
Rb1 is often used to represent the panaxadiol ginsenosides 
and Rg1 often represents the panaxatriol ginsenosides. 
Both Rb1 and Rg1 are thought to improve cognitive func-
tion [3,4]. Ginsenosides act through diverse mechanisms, 
and it has been suggested that each ginsenoside has its 
own tissue-specifi c effects [5]. Although there is a large 
body of work attesting to the cognition-enhancing effects 
of ginseng in animals, there is little evidence of such ef-
fects following the chronic administration of ginseng in 
humans.
Jin et al. [6] studied the effects of red ginseng extract 
on learning and memory impairments induced by sco-
polamine. Scopolamine increases acetylcholinesterase 
activity and reduces acetylcholine in the synaptic cleft, 
resulting in impaired cognitive function. The red ginseng 
treatment group had improved Morris water maze test 
scores (reduced total swimming time) compared with the 
saline-treated group. This result suggests that red ginseng 
may be a cognitive enhancer. However, Lee et al. [7] 
also studied the cognition-enhancing effect of ginseng 
extracts using the Morris water maze test and did not fi nd 
any direct evidence of a pharmacological mechanism 
through which ginseng therapy might improve cognitive 
function.
Korean red ginseng was shown in another study to 
signifi cantly reduce the latency of the P300 component 
of an evoked potential [8]. This fi nding suggests that Ko-
rean red ginseng can directly modulate cerebro-electrical 
activity. Kennedy and Scholey [9] similarly suggested 
that ginseng may be a cognitive enhancer. However, fur-
ther studies are needed to investigate which brain regions 
are affected by ginseng. 
The current study used the P300 event-related poten-
tial (ERP) and the computerized neurocognitive func-
tion test (Vienna test system) to investigate the effect of 
Korean red ginseng on cognitive performance. First, we 
analyzed the P300 event-related potential [10] to confi rm 
previous study fi ndings that Korean red ginseng reduces 
P300 latency in the left temporal and occipital lobes, 
which is related to immediate memory and behavior re-
action time. The P300 event-related potential is thought 
to refl ect the neurophysiological activity related to cog-
nitive processes, such as attention, discrimination, and 
working memory [11]. Second, we used a computerized 
neurocognitive function test (Vienna test system) [12] as 
an objective and accurate measure of the effects of Ko-
rean red ginseng on cognitive and fi ne motor functions.
MATERIALS AND METHODS 
Participants 
A total of 20 healthy young male volunteers aged 19 
to 25 years were recruited through on-line and off-line 
advertisements for inclusion in this study. Prior to partici-
pation, each volunteer signed an informed consent form. 
Participants were interviewed by a board-certified psy-
chiatrist to ensure that none of the participants had psy-
chiatric disorders or cognitive problems. After assessment 
with the Annett handedness inventory [13], we identifi ed 
15 right-handed volunteers for inclusion in this study. 
Procedure
The 15 subjects included in this study were randomly 
assigned to either the red ginseng group or the placebo 
group: 8 received red ginseng and 7 received a placebo 
over a 2-week period. The ginseng group was admin-
istered 1,500 mg ginseng three times per day for a total 
daily dose of 4,500 mg (1 tablet=300 mg). The ginsen-
osides, the active constituents of Korean red ginseng, 
were composed of Rb1 (1.96%), Rb2 (2.18%), Rc (1.47%), 
Rd (0.72%), Re (1.11%), Rf (0.24%), Rg1 (0.49%), Rg2 
(0.13%), Rg3 (0.12%), Rh1 (0.12%), and Rh2 (0.003%) 
and accounted for 8.54% of the herb. During the 2-week 
trial period, the subjects were instructed to refrain from 
taking medications and drinking excessive amounts of 
alcohol. 
The P300 ERP [10] and computerized neurocogni-
tive function test [11] were performed at baseline and 
repeated 2 wk later. The effects of red ginseng and the 
placebo on cognitive function were assessed by compar-
ing the changes in the two groups over the trial period in 
the P300 ERP and Vienna test system scores. 
Neurocognitive function test 
The computerized neurocognitive function test (Vienna 
test system version IX) [12] was used to evaluate cogni-
tive function. Descriptions of the test categories are as 
follows [14]:
 Vigilance
The subject is presented with a large circle composed 
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of small rings. A point travels along the circular path 
from one ring to the next. Occasionally, however, one 
ring is skipped and the point jumps to the next ring on 
the circle. When this occurs, the subject has to respond 
by pressing the central key on the test subject panel. This 
test, which takes approximately 25 min, evaluates the 
subject’s ability to sustain alertness after extended expo-
sure to a low-level and monotonous stimulus. 
Reaction unit
This test is designed to determine the reaction time in 
response to a visual stimulus. The subject places his or 
her hand on the rest button and is required to push it im-
mediately whenever he or she detects a visual stimulus. 
The total testing time is 10 to 15 min.
Motor performance series
Several different fi ne motor skills of the left and right 
arms, hands and fingers are assessed by testing steadi-
ness, aiming, tapping, and pegboard performance. In 
the current study, different subtests were applied using 
the commercially available ‘MLS’ of the Vienna test 
system, which consists of a standardized metal work top 
(300×300×15 mm) with holes and contact fi elds for the 
different subtests [15]. Two contact pencils are connected 
to the sides of the worktop. The number and duration of 
contacts between pencils and the test board are measured 
as closures in the electrical circuits (5 V, 20 mA). The data 
are transferred via an interface to a computer for analysis.
Event-related potential test 
The P300 ERP [10] were obtained in a room free of 
noise and electrical fi elds. The subjects were seated in a 
comfortable armchair. The active electrode was attached 
to the vertex (Cz), reference electrodes were attached to 
A1 (A2), and the ground electrode was attached to the 
forehead (Fpz). The electrooculogram was recorded from 
electrodes placed above and below the outer corner of 
the right eye. 
During the P300 recording, subjects were instructed to 
avoid excessive movement of the face, eyes, and neck. 
The subjects were cooperative, and few trials were re-
jected due to artifacts. In the ERP to target stimuli, P300 
was identified as the highest positive component that 
appeared 250 to 500 ms after stimulation. Latency was 
calculated as the time required to obtain the P300 peak 
[12].
Statistical analysis
For comparison of the demographic variables be-
tween the two groups, an independent t-test was per-
formed using SPSS ver. 15.0 (SPSS Inc., Chicago, IL, 
USA). Inter-group comparisons of changes in P300 
ERP and computerized neurocognitive function test 
variables were assessed using a repeated measures 
ANOVA. All of the statistical analyses were two-
tailed, and the level of statistical signifi cance was set at 
p<0.05.




Baseline  2 wk Baseline  2 wk
Median reaction time (msec) 5592.1 (101.2) 5544.8 (72.3) 5579.0 (92.9) 5604.2 (105.0) 0.659 0.028
Median decision time (msec) 5421.0 (63.5) 5392.6 (49.9) 5382.7 (64.8) 5417.2 (83.4) 0.728 0.056
Median motor time (msec) 5152.0 (25.1) 5145.1 (25.9) 5190.8 (44.3) 5173.2 (42.7) 0.896 0.260
Wrong decision 550.13 (0.35) 550.38 (0.52) 550.00 (0.00) 550.50 (0.55) 0.959 0.487
Right reaction 558.00 (0.00) 557.88 (0.35) 557.67 (0.52) 557.83 (0.41) 0.854 0.178
Incomplete reaction 550.00 (0.00) 550.13 (0.35) 550.17 (0.41) 550.00 (0.00) 0.171 0.178
Values are given as mean (SD) scores.




Baseline 2 wk Baseline 2 wk
No. of correct 99.3 (1.0) 92.1 (17.9) 98.7 (1.7) 97.3 (2.9) 0.949 0.416
Mean value of reaction time (s) 0.45 (0.06) 0.48 (0.08) 0.53 (0.12) 0.53 (0.14) 0.965 0.507
No. of incorrect 0.50 (1.41) 1.13 (2.80) 1.00 (0.58) 0.71 (1.11) 0.873 0.192
No. of missed 0.71 (1.11) 1.57 (1.40) 1.29 (1.70) 2.71 (2.87) 0.966 0.529
Values are given as mean (SD) scores.
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RESULTS 
There were no signifi cant differences in the Vienna test 
scores between the red ginseng group and the placebo 
group (Tables 1-3). However, in the ERP test, the C3 la-
tency of the red ginseng group tended to decrease during 
the study period (Table 4). There were also significant 
decreases in the latencies of Cz (p=0.008), C3 (p=0.005), 
C4 (p=0.002), and C mean (p=0.003) in the red ginseng 
group. In addition, the red ginseng group showed a 
greater decrease in P300 voltage difference from baseline 
compared with the placebo group (Fig. 1) (at time=[0.30-
0.35], red circle) according to brain mapping. 
DISCUSSION
In our study, the red ginseng group showed a de-
creased latency of P300 in the central area (Cz, C3, C4, 




Baseline 2 wk Baseline 2 wk
Right Aiming error 550.75 (1.17) 551.50 (2.73) 550.86 (0.90) 550.57 (0.54) 0.930 0.339
Aiming H 5520.1 (0.4) 5520.3 (0.5) 5519.6 (0.8) 5520.0 (0.0) 0.950 0.425
Aiming T 556.57 (1.00) 556.83 (1.04) 556.41 (0.73) 556.18 (0.75) 0.855 0.161
Insertion long pins T 5537.2 (2.1) 5536.8 (4.2) 5540.6 (4.0) 5539.3 (3.9) 0.988 0.698
Steadiness error 551.00 (2.07) 551.25 (1.04) 553.71 (6.02) 550.71 (1.11) 0.874 0.194
Line tracking error 5518.0 (8.6) 5513.3 (6.0) 5518.9 (6.2) 5514.1 (5.7) 1.0 0.993
Line tracking T 5527.6 (11.3) 5526.5 (8.9)5 5526.3 (7.0) 5525.1 (13.5) 1.0 0.984
Tapping H 5227.9 (23.4) 5225.5 (17.1) 5180.1 (37.7) 5191.6 (13.8) 0.93 0.341
Inserting short pins T 5545.2 (5.9) 5547.3 (4.3) 5545.8 (5.4) 5552.4 (10.4) 0.84 0.214
Left Aiming error 554.88 (5.22) 553.00 (3.34) 552.86 (2.27) 554.14 (2.12) 0.854 0.160
Aiming H 5520.6 (1.5) 5520.1 (1.1) 5519.9 (0.4) 5519.7 (1.1) 0.987 0.689
Aiming T 559.59 (2.47) 559.16 (1.65) 558.18 (1.38) 558.02 (1.93) 0.992 0.758
Inserting long pins T 5544.1 (4.9) 5542.6 (6.2) 5543.4 (2.6) 5541.8 (5.0) 1.0 0.963
Steadiness error 551.38 (2.50) 555.75 (9.30) 550.71 (1.25) 551.00 (1.92) 0.862 0.173
Line tracking error 5526.4 (8.9) 5527.0 (5.3) 5528.4 (7.8) 5527.0 (5.3) 0.983 0.643
Line tracking T 5526.3 (8.5) 5524.0 (6.5) 5524.8 (8.4) 5525.5 (12.8) 0.953 0.436
Tapping H 5178.8 (28.6) 5175.8 (29.6) 5169.6 (33.8) 5182.3 (24.3) 0.897 0.242
Inserting short pins T 5553.0 (11.3) 5555.0 (6.6) 5554.0 (5.4) 5551.3 (6.3) 0.919 0.302
Both Steadiness error (R) 552.13 (4.85) 550.88 (2.48) 550.00 (0.00) 553.57 (7.76) 0.868 0.183
Steadiness error (L) 550.75 (1.17) 550.63 (0.92) 556.14 (15.4) 552.86 (4.18) 0.976 0.582
Inserting long pins T (R) 5557.5 (7.8) 5555.9 (6.0) 5562.0 (12.0) 5557.4 (6.1) 0.962 0.487
Inserting long pins T (L) 5558.6 (8.9) 5556.5 (7.5) 5562.8 (11.7) 5558.5 (5.9)5 0.982 0.630
Aiming error (R) 553.00 (2.93) 552.13 (2.03) 551.14 (1.68) 551.00 (1.16) 0.961 0.482
Aiming H (R) 5521.3 (1.0) 5520.3 (1.7) 5520.1 (1.2) 5520.0 (0.6) 0.931 0.343
Aiming T (R) 5512.4 (3.8) 5512.3 (4.8) 5510.3 (1.5) 5559.8 (1.5) 0.991 0.732
Aiming H (L) 5523.0 (4.9) 5520.9 (2.9) 5519.7 (1.6) 5518.3 (2.4) 0.979 0.602
Aiming T (L) 5512.3 (3.6) 5513.0 (5.5) 5510.4 (1.6) 5559.8 (1.6) 0.925 0.324
Tapping H (R) 5188.1 (36.3) 5191.9 (33.1) 5172.4 (36.2) 5178.9 (27.5) 0.991 0.734
Tapping H (L) 5174.9 (40.3) 5168.9 (22.9) 5173.7 (23.9) 5163.6 (32.6) 0.985 0.668
Inserting short pins T (R) 5568.7 (15.8)5 5566.9 (9.8)5 5571.3 (11.9) 5575.2 (15.0) 0.957 0.458
Inserting short pins T (L) 5568.4 (13.7) 5568.8 (9.5) 5573.7 (10.6) 5576.8 (15.2) 0.988 0.703
Values are given as mean (SD) scores.
H, number of hitting; T, time required for performance; R, right; L, left.
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and C mean) compared with baseline using a paired t-
test. Although effi cacy in animals does not guarantee ef-
fi cacy in humans, our results are consistent with previous 
fi ndings that Korean red ginseng decreases the latency of 
P300 in animal tests [8,9,16].
The P300 component of ERP is used as a marker of 
cognitive function and is related to the decision-making 
process [17]. The P300 amplitude is thought to be an 
index for brain activity [18] and can be viewed as a mea-
sure of central nervous system activity that processes 
incoming information into memory representations of the 
stimulus and its context. The P300 amplitude, therefore, 
is assumed to reflect the degree or quality with which 
that information is processed.
P300 latency is considered to be a measure of stimulus 
classifi cation speed and is generally unrelated to response 
selection processes. It is, therefore, independent of be-
havioral reaction time. These properties make the P300 
a valuable tool for assessing cognitive function. Because 
P300 latency is an index of the processing time required 
before response generation, it is a sensitive temporal 
measure of the neural activity underlying the processes of 
attention allocation and immediate memory. In addition, 
P300 latency is negatively correlated with mental func-
tion in normal subjects, with shorter latencies and am-
plitudes associated with superior cognitive performance 
[19]. Kennedy and Scholey [9] found that red ginseng 
decreased the P300 latency in the left temporal and oc-
cipital lobes. However, our study found that Korean red 
ginseng decreased the latency of P300 in the central area. 
Table 4. Changes in event-related potential test results between red ginseng and placebo groups during the 2-week trial 
Red ginseng Placebo
Wilks Λ p-value
Baseline 2 wk Baseline 2 wk
Frontal 
Fz latency 369.29 (14.19) 365.71 (18.54) 361.07 (11.79) 357.14 (12.57) 1.0 0.975
Fz amplitude 556.23 (5.43) 510.64 (3.89) 556.84 (4.34) 557.68 (3.32) 0.863 0.193
F4 latency 368.57 (10.51) 5367.5 (13.63) 354.29 (11.16) 358.21 (11.47) 0.975 0.586
F4 amplitude 557.48 (4.64) 511.51 (4.11)5 557.05 (4.78) 559.83 (3.76) 0.980 0.632
F3 latency 366.43 (12.16) 361.79 (14.86) 362.14 (10.39) 362.59 (14.58) 0.962 0.501
F3 amplitude 556.74 (5.77) 511.07 (4.36) 557.05 (3.99) 557.64 (2.45) 0.788 0.098
Mean (F3, F4, Fz) latency 368.09 (10.9) 5 5365 (14.48) 359.17 (9.78) 359.29 (8.57) 0.978 0.612
Mean (F3,F4,Fz) amplitude 556.74 (5.77) 511.07 (4.36)  556.98 (4.53) 558.38 (3.26) 0.883 0.230
Central
Cz latency 372.50 (13.5) 367.14 (15.32) 363.57 (13.55) 355.71 (9.97) 0.992 0.762
Cz amplitude 510.38 (5.83) 5513.2 (4.67) 511.06 (5.08) 510.81 (4.74) 0.888 0.242
C3 latency 374.29 (12.59) 5367.5 (16.42) 359.29 (14.25) 363.21 (11.7) 0.674 0.033
C3 amplitude 559.69 (5.61) 5513.1 (4.45) 510.36 (4.64) 510.44 (3.66) 0.854 0.156
C4 latency 372.14 (13.59) 368.57 (14.87) 5362.5 (14.14) 5367.5 (14.14) 0.925 0.344
C4 amplitude 511.57 (4.67) 514.24 (5.23) 559.86 (5.06) 510.53 (3.54) 0.939 0.396
Mean (C3, C4, Cz) latency 372.98 (14.19) 367.79 (16.71) 361.79 (10.38) 362.14 (7.13) 0.920 0.327
Mean (C3, C4, Cz) amplitude 510.55 (5.71) 513.51 (5.09) 510.43 (5.33) 5510.6 (4.22) 0.891 0.250
Parietal
Pz latency 372.14 (14.17) 358.57 (11.29) 5367.5 (11.34) 356.43 (9.62) 0.998 0.888
Pz amplitude 514.21 (4.97) 515.61 (6.13) 511.73 (4.97) 512.36 (4.49) 0.994 0.801
P3 latency 372.14 (13.12) 368.21 (9.79) 367.14 (16.06) 358.93 (8.22) 0.987 0.697
P3 amplitude 513.44 (4.75) 514.46 (4.47) 511.60 (5.26) 512.28 (3.32) 0.999 0.897
P4 latency 370.36 (14.36) 372.14 (10.3) 365,36 (12.85) 55.360 (12.89) 0.966 0.526
P4 amplitude 513.51 (3.72) 514.51 (6.71) 510.31 (5.12) 511.54 (3.98) 0.999 0.938
Mean (P3, P4, Pz) latency 371.58 (14.89) 366.31 (13.74) 366.67 (11.93) 358.45 (9.11) 0.992 0.768
Mean (C3, C4, Cz) amplitude 513.72 (4.75) 514.86 (6.14) 511.21 (5.43) 512.06 (4.18) 0.999 0.919
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Further studies are necessary to investigate which brain 
regions are affected by Korean red ginseng. 
Our results support only one of our hypotheses, which 
is that Korean red ginseng decreases P300 latency re-
lated to cognitive function, but not our other hypothesis 
that it would improve Vienna test scores of fine motor 
performance. Several possible explanations can be pro-
posed for this unexpected finding. One explanation is 
that improvement in fi ne motor performance may not be 
associated with decreased P300 latency. Another possible 
explanation is that for the distinctive effi cacy of fi ne mo-
tor movement, a longer trial of red ginseng is needed to 
observe improvements. 
The most prominent ERP components widely ob-
served in studies of cognitive function are N100, P200, 
P300, and N200. The expectancy of motor response has 
been suggested to be a major factor modulating scalp-re-
corded P300. Verleger et al. [20] performed a Go/NoGo 
test to explore the motor-related activation of cognitive 
function measured with P300 and N200. The study con-
firmed that the N200 and P300 effects were not solely 
due to movement-related potentials and suggested P300 
as a marker of motor inhibition. Thus, further studies are 
needed to measure other ERP components to confirm 
the effi cacy of Korean red ginseng for fi ne motor perfor-
mance. 
Wesnes et al. [21] performed a 12-week ginseng trial 
with 256 healthy middle-aged volunteers and used the 
computerized cognitive assessment system to study 
the effects of ginseng treatment. In their study, the gin-
seng group demonstrated improved memory, including 
working and long-term memory. A few studies have 
Fig. 1. Voltage difference between red ginseng and placebo group at baseline (A) and after 2 wk (B). The red ginseng group showed a greater 
decreased in P300 voltage difference from baseline compared with that of the placebo group during 2-week trial period (at time=[0.30-0.35], red 
circle), according to brain mapping.
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identified cholinergic properties associated with single 
ginsenosides, such as a direct interaction between Rg2 
and nicotinic receptor subtypes [22], the modulation 
of acetylcholine release and reuptake by Rb1, and the 
number of choline uptake sites in the hippocampus. The 
hippocampus is located in the temporal lobe and plays 
important roles in the consolidation of information from 
short-term to long-term memory. The ginsenosides Rg1 
and Rb1 have also been shown to increase choline acetyl-
transferase levels in rodent brains, which may contribute 
to cognitive function enhancement in such areas as work-
ing and long-term memory [23].
The exact mechanism through which ginseng enhanc-
es cognitive function is still unknown, but one report has 
indicated that ginseng might improve cognitive function 
by modulating neurotransmission. Petkov [24] found 
that ginseng administration (50 mg/kg) led to increased 
dopamine and norepinephrine in the brainstem and in-
creased serotonin in the cortex. This effect was abolished 
by the administration of either a serotonin receptor ago-
nist or a specific serotonin antagonist, suggesting that 
serotonergic transmission is involved in the memory-
enhancing effect of ginseng. Wang et al. [25] also found 
that both root and stem/leaf saponins improved learning 
and increased the levels of biogenic monoamines in nor-
mal rat brains. These effects are thought to be necessary 
changes of neuroplasticity at the synapse level, which 
may require several months. Although the mechanism of 
behavior reaction time is not the same as memory func-
tion, improvements in reaction time may require long-
term ginseng administration. This hypothesis suggests 
that our study trial of two weeks may have been too short 
to observe any effect from the ginseng treatment.
There are some limitations to our study. First, the 
sample size was too small (n=15), and the trial dura-
tion was too short (2 wk). Second, in the experimental 
design, we could not control for the practice effect on 
our measurements using the computerized neurocogni-
tive function test. Third, the dosage of ginseng may have 
been inadequate. The recommended daily dose of gin-
seng for humans is 1.5 to 3.0 g/d [26], whereas Heo et al. 
[27] used ginseng doses up to 9.0 g/d to show improved 
cognitive function. The dosage we used in this study may 
have been too low to produce an effect. Fourth, because 
of the small sample size, our data were analyzed using 
nonparametric statistics. 
In conclusion, subjects who received Korean red gin-
seng showed a decreased latency of P300 in the central 
region (Cz, C3, C4, and C mean). However, there were 
no signifi cant changes in Vienna test scores between the 
red ginseng group and the placebo group after 2 wk. The 
observed decreased latency in ERP may indicate an im-
provement in cognitive function, especially in association 
with attention allocation, immediate memory and behav-
ior reaction time. Our fi ndings warrant further study with 
a higher ginseng dose, a larger sample size, and a longer 
follow-up period to confi rm the clinical effi cacy of Ko-
rean red ginseng.
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